AI assistant
Vericel Corp — Director's Dealing 2025
Feb 19, 2025
31799_dirs_2025-02-19_4a658e24-353f-420f-8330-334fe1e1cde7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2025-02-19
Reporting Person: Mahoney Karen (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $51.58 | 2034-07-22 | Common Stock (75000) | Direct | |
| Restricted Stock Unit | $ | Common Stock (10500) | Direct |
Footnotes
F1: These options began vesting on July 22, 2024. On the first anniversary of the date of grant, July 22, 2025, 25% of the options shall vest and become exercisable, with the remaining 75% vesting in equal quarterly installments over three (3) years thereafter.
F2: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
F3: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on July 22, 2025. The remaining RSUs will vest in annual installments on July 22, 2026, July 22, 2027, and July 22, 2028, respectively.
F4: No expiration date for this type of award.